Abstract:Objective To investigate the safety and efficacy of high-voltage, long-duration pulsed radiofrequency in the treatment of the branch I-trigeminal neuralgia. Method A total of 63 patients(25 males and 38 females, aged 62.64±11.27 years)with post-herpetic branch I-trigeminal neuralgia admitted to the Department of Pain Medicine of Yunnan First People's Hospital from January 2020 to September 2022 were retrospectively selected. Patients were divided into two groups based on the treatment: pulse group (control group, n=30) and high-voltage group (experimental group, n=33). Guided by the C-arm, percutaneous puncture was performed at 1/3 of the inner foramen ovalis. The radiofrequency thermocoagulation instrument and the accompanying electrode were connected. Sensory and motor tests were performed to determine the area innervated by the trigeminal nerve of Branch I. Pulse radiofrequency (42 ℃, 360 s, 45 V) or high voltage long-term radiofrequency (42 ℃, 900 s, 40-100 V, were performed, and the voltage was gradually increased. Until the patient can no longer tolerate it). The visual analogue Scale (NRS) and the 36-item Concise Health Scale (SF-36) were evaluated at different time points to assess the efficacy, patients discharged from hospital were followed up by telephone, as well as the clinical effective rate and postoperative complications. Result There was no significant difference in preoperative baseline data between the two groups. NRS scores in the pulse group and the high-voltage group before treatment were (7.6 ± 0.89) and (7.58 ± 0.83), respectively, with no statistical significance (P>0.05). At 3 days, 3 months, 6 months and 12 months, NRS scores in the pulse group were (6.1 ± 1.06), (5.3 ± 0.95), (4.63 ± 0.85) and (4.8±0.89) respectively, while those in the high-voltage group were (4.73 ± 1.15), (3.61 ± 1.27), (3.36 ± 1.45) and (3.7±1.24)respectively. The NRS score and oral pregabalin dose of the two groups showed a downward trend, while the SF-36 showed an upward trend, and there were statistical differences at each time point compared with preoperation (P<0.0001), and the results of the high-voltage group were significantly better than those of the pulse group at the same post-operative time point except for the drug dose in the 12th month after surgery (P<0.0001). 12 months after operation, the clinical effective rate of high-voltage group (69.7%) was significantly higher than that of pulse group (23.3%) (P = 0.0004). The incidence of adverse reactions was 16.7% in the pulse group and 15.2% in the high voltage group, the difference was not statistically significant (P>0.9999). Conclusion Under the guidance of C-arm, both pulse radiofrequency therapy and high-voltage, long-duration radiofrequency therapy could safely and effectively relieve the pain of post-herpetic branch I-trigeminal neuralgia and reduce the dose of pregabalin, while improving the quality of life of patients, and the latter effect is better, and there are no obvious complications in both radiofrequency modalities. 【Keywords】Postherpetic Branch I-trigeminal neuralgia; High-voltage, long-duration radiofrequency; Pulsed radiofrequency; Numerical Rating Scale; 36-Item short health scale